VasicineCAS# 6159-55-3 |
- (±)-Vasicine
Catalog No.:BCN9106
CAS No.:6159-56-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 6159-55-3 | SDF | Download SDF |
| PubChem ID | 442929 | Appearance | Powder |
| Formula | C11H12N2O | M.Wt | 188.2 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | DMSO : 83.33 mg/mL (442.70 mM; Need ultrasonic) | ||
| Chemical Name | (3R)-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-3-ol | ||
| SMILES | C1CN2CC3=CC=CC=C3N=C2C1O | ||
| Standard InChIKey | YIICVSCAKJMMDJ-SNVBAGLBSA-N | ||
| Standard InChI | InChI=1S/C11H12N2O/c14-10-5-6-13-7-8-3-1-2-4-9(8)12-11(10)13/h1-4,10,14H,5-7H2/t10-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Vasicine is oxytocic and abortifacient agents. 2. Vasicine, a potential natural cholinesterase inhibitor, has been in development for treatment of Alzheimer's disease. 3. Vasicine can regulate the inflammatory reaction, have great potentials to develop safe medications for respiratory and reproductive medicine. |
| Targets | Antifection | AChR |
Vasicine Dilution Calculator
Vasicine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.3135 mL | 26.5675 mL | 53.135 mL | 106.2699 mL | 132.8374 mL |
| 5 mM | 1.0627 mL | 5.3135 mL | 10.627 mL | 21.254 mL | 26.5675 mL |
| 10 mM | 0.5313 mL | 2.6567 mL | 5.3135 mL | 10.627 mL | 13.2837 mL |
| 50 mM | 0.1063 mL | 0.5313 mL | 1.0627 mL | 2.1254 mL | 2.6567 mL |
| 100 mM | 0.0531 mL | 0.2657 mL | 0.5313 mL | 1.0627 mL | 1.3284 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- DHBP dibromide
Catalog No.:BCC6811
CAS No.:6159-05-3
- Acetylatractylodinol
Catalog No.:BCN8111
CAS No.:61582-39-6
- L-Rhamnose
Catalog No.:BCN6302
CAS No.:6155-35-7
- Verbasoside
Catalog No.:BCN8197
CAS No.:61548-34-3
- Oxytetracycline Dihydrate
Catalog No.:BCC4820
CAS No.:6153-64-6
- (+)-Nortrachelogenin
Catalog No.:BCN7020
CAS No.:61521-74-2
- Quercetin Dihydrate
Catalog No.:BCN2967
CAS No.:6151-25-3
- alpha-Mangostin
Catalog No.:BCN4138
CAS No.:6147-11-1
- Lup-20(29)-ene-2alpha,3beta-diol
Catalog No.:BCN4612
CAS No.:61448-03-1
- CIS-Resveratrol
Catalog No.:BCC8150
CAS No.:61434-67-1
- Bisabola-3,10-dien-2-one
Catalog No.:BCN7510
CAS No.:61432-71-1
- Z-D-Ala-ol
Catalog No.:BCC2589
CAS No.:61425-27-2
- 15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene
Catalog No.:BCN1400
CAS No.:61597-55-5
- 13-Hydroxy-8,11,13-podocarpatrien-18-oic acid
Catalog No.:BCN1399
CAS No.:61597-83-9
- H-DL-Nle-OH
Catalog No.:BCC3301
CAS No.:616-06-8
- Acetylcysteine
Catalog No.:BCC3716
CAS No.:616-91-1
- (-)-Sparteine Sulfate Pentahydrate
Catalog No.:BCC8273
CAS No.:6160-12-9
- Songoroside A
Catalog No.:BCN3988
CAS No.:61617-29-6
- Amfenac Sodium Monohydrate
Catalog No.:BCC4620
CAS No.:61618-27-7
- Protopine hydrochloride
Catalog No.:BCN5345
CAS No.:6164-47-2
- Propargyl benzenesulfonate
Catalog No.:BCN2247
CAS No.:6165-75-9
- Propargyl p-toluenesulfonate
Catalog No.:BCN2266
CAS No.:6165-76-0
- MK 212 hydrochloride
Catalog No.:BCC6856
CAS No.:61655-58-1
- Furomollugin
Catalog No.:BCN4141
CAS No.:61658-41-1
In vitro and in vivo metabolism and inhibitory activities of vasicine, a potent acetylcholinesterase and butyrylcholinesterase inhibitor.[Pubmed:25849329]
PLoS One. 2015 Apr 7;10(4):e0122366.
Vasicine (VAS), a potential natural cholinesterase inhibitor, exhibited promising anticholinesterase activity in preclinical models and has been in development for treatment of Alzheimer's disease. This study systematically investigated the in vitro and in vivo metabolism of VAS in rat using ultra performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry. A total of 72 metabolites were found based on a detailed analysis of their 1H- NMR and 13C NMR data. Six key metabolites were isolated from rat urine and elucidated as vasicinone, vasicinol, vasicinolone, 1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-yl hydrogen sulfate, 9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-yl hydrogen sulfate, and 1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-beta-D-glucuronide. The metabolic pathway of VAS in vivo and in vitro mainly involved monohydroxylation, dihydroxylation, trihydroxylation, oxidation, desaturation, sulfation, and glucuronidation. The main metabolic soft spots in the chemical structure of VAS were the 3-hydroxyl group and the C-9 site. All 72 metabolites were found in the urine sample, and 15, 25, 45, 18, and 11 metabolites were identified from rat feces, plasma, bile, rat liver microsomes, and rat primary hepatocyte incubations, respectively. Results indicated that renal clearance was the major excretion pathway of VAS. The acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities of VAS and its main metabolites were also evaluated. The results indicated that although most metabolites maintained potential inhibitory activity against AChE and BChE, but weaker than that of VAS. VAS undergoes metabolic inactivation process in vivo in respect to cholinesterase inhibitory activity.
Enzyme inhibition, antioxidant and antibacterial potential of vasicine isolated from Adhatoda vasica Nees.[Pubmed:22713956]
Pak J Pharm Sci. 2012 Jul;25(3):651-6.
Vasicine (1) was isolated from the ethanolic extract of Adhatoda vasica Nees (Acanthaceae) and the structure was confirmed using spectroscopic techniques. Acetylcholine esterase, trypsin, DPPH inhibition potential and FRAP assay were carried out using in vitro models. The results showed 38.4 +/- 1.2% and 37.4 +/- 1.1% activity in acetylcholine and trypsin inhibition assays respectively. The compound (1) exhibited significant DPPH inhibition activity (70.4 +/- 1.3%, IC(50) = 212.3 +/- 1.9 muM). A dose dependant behavior of Vasicine (1), was indicated in the FRAP assay. Antibacterial activity was checked according to agar well diffusion assay and results revealed that Vasicine (1) showed moderate activity.
